News Related to NLR Family Pyrin Domain Containing 3

Related coverage linked through entity extraction aliases.

Insilico Medicine Advances AI Drug Discovery Platform with New Partnership and Candidate Nomination

Mar 19, 2026

Insilico Medicine announced a partnership with China Medical System Holdings for AI-powered drug discovery and nominated ISM5059, an NLRP3-targeted drug candidate, for preclinical development following recent FDA IND approval for another AI-created drug.

Drug Discovery Patent Filings Span Protein Degradation, Ion Channels, and Emerging Targets

Feb 25, 2025

Monthly patent reviews from April through December 2025 highlight notable drug discovery IP disclosures across targeted protein degradation, small molecule modulators, and emerging therapeutic targets in oncology, immunology, and neurology.